MedVital Strengthens India’s Regenerative Healthcare Ecosystem

Indian medtech startup MedVital has raised Rs 18 crore in a growth funding round led by Alkemi Growth Capital, with participation from Dr. Sanjay Arora, Shubhan Ventures, and existing investors. The fresh capital will help the company expand operations, strengthen product innovation, and improve supply chain capabilities across its regenerative healthcare portfolio.

Founded in 2024, MedVital is building advanced technologies focused on wound healing, skin regeneration, chronic dermatology, and aesthetic care. The startup aims to bridge the growing gap in evidence-based regenerative treatment solutions in India’s healthcare ecosystem.

Focused on Advanced Wound Care and Regenerative Aesthetics

MedVital operates through two major product portfolios designed for different healthcare segments.

The first portfolio, NoWound, focuses on advanced wound care technologies. It includes solutions like Negative Pressure Wound Therapy and a chitosan-based liquid bandage developed specifically for hospitals and healthcare institutions. The company claims to have already achieved adoption across more than 200 corporate and public healthcare centers, highlighting strong early clinical traction.

Its second portfolio, Elyara, targets the regenerative medical aesthetics market with non-invasive skin and hair restoration solutions. The brand leverages peptide-led signaling and regenerative pathways to address ageing, hair loss, and chronic skin conditions through science-backed treatments.

According to Co-Founder Dr. Varun Gupta, rising cases of diabetes, ageing-related disorders, and chronic dermatological issues are increasing the demand for innovative regenerative healthcare technologies. MedVital plans to make advanced biomaterials, biologics, and device-driven systems more accessible for real-world clinical use.

Funding to Accelerate Product Development and Expansion

The newly raised funds will primarily support product development, operational scaling, and capability building across devices, biomaterials, and biologics. The startup also plans to improve manufacturing and supply chain efficiency to meet increasing demand in the advanced wound care and regenerative treatment sectors.

Investors believe MedVital’s platform-driven approach positions the company strongly within India’s fast-growing healthcare innovation landscape. Alka Goel noted that the company has demonstrated disciplined execution, strong product depth, and promising early hospital adoption.

Healthcare-focused investors also highlighted MedVital’s emphasis on product quality, regulatory readiness, and sustainable long-term growth as key differentiators in the medtech sector.

India’s Regenerative Healthcare Market Shows Massive Potential

As awareness around advanced wound management, regenerative aesthetics, and chronic skin treatment continues to grow, startups like MedVital are helping reshape India’s healthcare innovation ecosystem. With increasing clinical adoption and strong investor confidence, the company is positioning itself as a significant player in regenerative care technologies built from India for global markets.

Featured on The Startup Caffe

Featured on The Startup Caffe, the platform continues to spotlight emerging startups, funding stories, and founders building innovative businesses across India’s startup ecosystem. Stay connected for more insights into healthcare innovation, medtech growth, and entrepreneurial success stories.